{"title":"慢性淋巴细胞白血病:“时代正在改变”。","authors":"Stefano Molica","doi":"10.2217/ijh-2017-0007","DOIUrl":null,"url":null,"abstract":"“ the advent of targeted therapy in CLL requires the urgent introduction of revised clinical guidelines based not only on results of clinical trials but also including data from clinical practice and the assessment of drug-related toxicity according patients’ reported outcomes ”","PeriodicalId":14166,"journal":{"name":"International Journal of Hematologic Oncology","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2017-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.2217/ijh-2017-0007","citationCount":"0","resultStr":"{\"title\":\"Chronic lymphocytic leukemia: <i>\\\"The times they are a-changin\\\"</i>.\",\"authors\":\"Stefano Molica\",\"doi\":\"10.2217/ijh-2017-0007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"“ the advent of targeted therapy in CLL requires the urgent introduction of revised clinical guidelines based not only on results of clinical trials but also including data from clinical practice and the assessment of drug-related toxicity according patients’ reported outcomes ”\",\"PeriodicalId\":14166,\"journal\":{\"name\":\"International Journal of Hematologic Oncology\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2017-06-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://sci-hub-pdf.com/10.2217/ijh-2017-0007\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"International Journal of Hematologic Oncology\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.2217/ijh-2017-0007\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2017/11/17 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"International Journal of Hematologic Oncology","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.2217/ijh-2017-0007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2017/11/17 0:00:00","PubModel":"Epub","JCR":"","JCRName":"","Score":null,"Total":0}
Chronic lymphocytic leukemia: "The times they are a-changin".
“ the advent of targeted therapy in CLL requires the urgent introduction of revised clinical guidelines based not only on results of clinical trials but also including data from clinical practice and the assessment of drug-related toxicity according patients’ reported outcomes ”
期刊介绍:
International Journal of Hematologic Oncology welcomes unsolicited article proposals. Email us today to discuss the suitability of your research and our options for authors, including Accelerated Publication. Find out more about publishing open access with us here.